Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited)

v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited) - USD ($)
$ in Thousands
Total
At-The-Market Public Offering
Private Placement
Common Stock
Common Stock
At-The-Market Public Offering
Common Stock
Private Placement
Additional Paid-In Capital
Additional Paid-In Capital
At-The-Market Public Offering
Additional Paid-In Capital
Private Placement
Accumulated Deficit
Accumulated Other Comprehensive Loss
Common stock, beginning balance (in shares) at Dec. 31, 2023       698,262,025              
Beginning balance at Dec. 31, 2023 $ 1,034,362     $ 70     $ 2,282,475     $ (1,247,703) $ (480)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income (loss) (94,587)                 (94,587)  
Stock-based compensation 35,328           35,328        
Issuance of common stock upon exercise of stock options (in shares)       1,016,414              
Issuance of common stock upon exercise of stock options 943           943        
Issuance of common stock upon the release of restricted stock units (in shares)       6,034,056              
Vesting of common stock issued in private placement and early exercised stock options 186           186        
Other comprehensive loss (1,101)                   (1,101)
Common stock, ending balance (in shares) at Mar. 31, 2024       705,312,495              
Ending balance at Mar. 31, 2024 975,131     $ 70     2,318,932     (1,342,290) (1,581)
Common stock, beginning balance (in shares) at Dec. 31, 2023       698,262,025              
Beginning balance at Dec. 31, 2023 1,034,362     $ 70     2,282,475     (1,247,703) (480)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income (loss) (217,879)                    
Common stock, ending balance (in shares) at Jun. 30, 2024       713,879,586              
Ending balance at Jun. 30, 2024 894,584     $ 71     2,362,128     (1,465,582) (2,033)
Common stock, beginning balance (in shares) at Mar. 31, 2024       705,312,495              
Beginning balance at Mar. 31, 2024 975,131     $ 70     2,318,932     (1,342,290) (1,581)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income (loss) (123,292)                 (123,292)  
Stock-based compensation 28,441           28,441        
Issuance of common stock upon exercise of stock options (in shares)       424,313              
Issuance of common stock upon exercise of stock options 312     $ 1     311        
Issuance of common stock upon the release of restricted stock units (in shares)       3,594,727              
Issuance of common stock under the Employee Stock Purchase Plan (in shares)       1,227,816              
Issuance of common stock under the Employee Stock Purchase Plan 4,942           4,942        
Issuance of common stock in acquisition (in shares)       3,320,235              
Issuance of common stock in acquisition 9,472           9,472        
Vesting of common stock issued in private placement and early exercised stock options 30           30        
Other comprehensive loss (452)                   (452)
Common stock, ending balance (in shares) at Jun. 30, 2024       713,879,586              
Ending balance at Jun. 30, 2024 $ 894,584     $ 71     2,362,128     (1,465,582) (2,033)
Common stock, beginning balance (in shares) at Dec. 31, 2024 784,176,364     784,176,364              
Beginning balance at Dec. 31, 2024 $ 912,363     $ 78     2,768,605     (1,855,737) (583)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income (loss) (82,406)                 (82,406)  
Stock-based compensation 27,019           27,019        
Issuance of common stock upon exercise of stock options (in shares)       807,475              
Issuance of common stock upon exercise of stock options 547           547        
Issuance of common stock upon the release of restricted stock units (in shares)       4,063,821              
Issuance of common stock (in shares)         246,167            
Issuance of common stock   $ 1,994     $ 1     $ 1,993      
Vesting of common stock issued in private placement and early exercised stock options 13           13        
Other comprehensive loss (89)                   (89)
Common stock, ending balance (in shares) at Mar. 31, 2025       789,293,827              
Ending balance at Mar. 31, 2025 $ 859,441     $ 79     2,798,177     (1,938,143) (672)
Common stock, beginning balance (in shares) at Dec. 31, 2024 784,176,364     784,176,364              
Beginning balance at Dec. 31, 2024 $ 912,363     $ 78     2,768,605     (1,855,737) (583)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income (loss) $ (407,080)                    
Common stock, ending balance (in shares) at Jun. 30, 2025 850,621,503     850,621,503              
Ending balance at Jun. 30, 2025 $ 898,292     $ 85     3,161,578     (2,262,817) (554)
Common stock, beginning balance (in shares) at Mar. 31, 2025       789,293,827              
Beginning balance at Mar. 31, 2025 859,441     $ 79     2,798,177     (1,938,143) (672)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income (loss) (324,674)                 (324,674)  
Stock-based compensation 26,558           26,558        
Issuance of common stock upon exercise of stock options (in shares)       886,924              
Issuance of common stock upon exercise of stock options 421           421        
Issuance of common stock upon the release of restricted stock units (in shares)       3,736,901              
Issuance of common stock (in shares)         5,853,452 49,701,790          
Issuance of common stock   $ 40,968 $ 290,163   $ 1 $ 5   $ 40,967 $ 290,158    
Issuance of common stock under the Employee Stock Purchase Plan (in shares)       1,148,609              
Issuance of common stock under the Employee Stock Purchase Plan 5,022           5,022        
Vesting of common stock issued in private placement and early exercised stock options 275           275        
Other comprehensive loss $ 118                   118
Common stock, ending balance (in shares) at Jun. 30, 2025 850,621,503     850,621,503              
Ending balance at Jun. 30, 2025 $ 898,292     $ 85     $ 3,161,578     $ (2,262,817) $ (554)